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ABSTRACT
Laryngopharyngeal reflux (LPR) is the reflux of gastric acid through the 
upper oesophageal sphincter causing mucosal damage of the larynx, the 
gastrointestinal tract, and the upper airway. Alkaline water has the ability to 
withstand acidic conditions in the body, the formation of carbonic anhydrase, 
and reepithelization. This study aimed to investigate the effect of alkaline water 
on the clinical improvement in LPR patients. A randomized control trial with 
pre-test and post-test control group design on LPR patients aged 18 to 60 y.o. 
was conducted  at the ENT-HS outpatient clinic of Dr Kariadi Central Hospital, 
Semarang, Central Java, Indonesia. Thirty subjects were recruited and divided 
into two group with 15 subjects in each group. In the control group, the subjects 
were given standard therapy and mineral water. In the treatment group, the 
subjects were given standard therapy and alkaline water. The diagnosis of 
LPR was made if the reflux scoring index (RSI) was ≥13, and the reflux finding 
score (RFS) was >7. ,After two weeks of intervention, the clinical improvements 
were evaluated by reassessing the RSI score. The data were analyzed using 
the Shapiro-Wilk test and independent t-test. The results showed that the most 
common main complaint was throat clearing [11 subjects (37%)]. Based on the 
RSI score, there were clinical improvements in both the control (p <0.001) and 
the treatment groups (p <0.001). However, there was no significant difference 
in the RSI score before and after the intervention in the control (p = 0.058) 
and the treatment groups (p = 0.322). In conclusion,tbe d there is an effect of 
alkaline water on the clinical improvement of LPR patients. However, there is 
no significant difference in the clinical improvement between the control and 
the treatment groups.
ABSTRAK
Laryngopharyngeal reflux (LPR) adalah naiknya cairan lambung melewati 
sfingter esofagus atas yang mencederai mukosa laring, faring, dan 
mukosa sepanjang saluran cerna dan saluran napas atas. Air alkali dapat 
mempertahankanenahan keasamam dalam tubuh, pembentukan enzim 
karbonat anhidrase, dan re-epitelisasi. Penelitian ini bertujuan untuk 
mengkaji pengaruh pemberian air alkali terhadap perbaikan klinis penderita 
LPR. Penelitian merupakan penelitian eksperimental dengan randomized 
control trial pre-post test design pada penderita LPR umur 18 hingga 60 tahun 
di klinik THT RSUP Dr. Kariadi Semarang, Jawa Tengah, IndonesiaIndonesia. 
Tigapuluh subjek direkrut dan dibagi dalam dua kelompok dengan masing-
masing kelompok 15 subjek. Kelompok kontrol diberikan terapi standart dan 
air mineral. Kelompok perlakuan diberikan terapi standart dan air alkali. 
Diagnosis LPR ditegakkan dengan reflux scoring index (RSI) >13, reflux finding 
score (RFS) >7. Pada hari ke 14 setelah intervensi, subjek dievaluasi perbaikan 
klinisnya dengan penilaian ulang skor RSI. Analisis statistic menggunakan 
uji Saphiro wilk dan independent t test. Hasil penelitian menunjukkan 
keluhan terbanyak berupa throat clearing sebanyak 11 subjek (37%). Rerata 
skor RSI mengalami perbaikan klinis baik pada kelompok kontrol (p<0,001) 
maupun kelompok perlakuan (p<0,001). Namun, rerata Skor RSI sebelum dan 
sesudah terapi tidak berbeda bermakna pada kelompok kontrol (p=0,058) dan 
kelompok perlakuan (p=0,322). Dapat disimpulkan bahwa terdapat pengaruh 
pemberian air alkali pada perbaikan klinis penderita LPR. Namun demikian, 
tidak terdapat perbedaan bermakna pada perbaikan klinis kelompok kontrol 
dan kelompok perlakuan.
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INTRODUCTION
Laryngopharyngeal reflux (LPR) is 
the reflux of gastric acid into the larynx, 
pharynx, trachea, and bronchi. The 
prevalence of LPR is 15% - 20% of the total 
patients visiting the ENT specialists.1 LPR 
occurs due to the high acid level. Alkaline 
water is currently used to neutralize the 
acidity because alkaline water with a pH 
of 8.8 can help to reduce acid reflux. The 
high pH level will inactivate pepsin, an 
enzyme involved in protein breakdown 
and the main cause of lower acidity. 
Apart from that, alkaline water has also 
been shown to reduce the acidity of 
stomach contents.2,3,4
Alkaline water has been established 
as fit for consumption and beneficial for 
the human body. One of its most important 
benefits is its ability to neutralize acidity 
in the body by reducing excess acid 
content in the stomach. Furthermore, 
alkaline water can boost the immune 
system, as well as neutralize acidity in 
the body caused by poor diet, stress, 
and environmental toxins. Alkaline 
water can also absorbed by the body, 
and is rich in alkaline minerals. With 
the -availability of abundance electrons, 
alkaline water allows the body cells to 
eliminate the harmful free radicals.5,6
Alkaline water with a pH of 8.8 can 
help reduce gastric acid reflux because 
higher pH levels will inactivate pepsin, 
an enzyme involved in dietary protein 
breakdown and the main cause of lower 
acidity.7,8 However, study concerning the 
effect of alkaline water on LPR patients 
has never been conducted. This study 
aimed to investigate the effect of alkaline 
water on the clinical improvement of 
LPR patients.
MATERIALS AND METHODS
Design and sample size
This was a randomized control trial 
with a pre-test and post-test control 
group design, conducted at the ENT-HS 
outpatient clinic of Dr. Kariadi Central 
Hospital, Semarang, Central Java. This 
study had obtained ethical approval from 
the Health Research Ethics Committee of 
Dr. Kariadi Central Hospital, Semarang. 
The sample size for each group was 
determined by the calculation formula 
used in previous studies. With the 
standard deviation of 4.7, α of 0.05, and 
power of 90%, the sample size obtained 
was 13.8, which was then rounded to 14. 
Then a drop-out count of 10% was added 
and the final sample size for each group 
consisted of 15 people.
Protocol of study
The diagnosis of LPR was conducted 
based on the reflux scoring index (RSI), 
a complete ENT examination, and 
reflux finding score (RFS) using flexible 
laryngoscopy/ fiberoptic laryngoscope 
(FOL). The diagnosis of LPR was 
established if the RSI score was ≥13 and 
the RFS score was >7. The samples were 
collected using consecutive sampling 
and single blinding methods.
The inclusion criteria of this study 
included: 1) patients with LPR (RSI of 
≥13; RFS of >7), 2) aged 18-60 years old, 
and 3) willing to take part in the study. 
Meanwhile, the exclusion criteria 
included: 1) patients with head and 
neck malignancies, 2) patients with 
acute lower and upper respiratory 
tract infections (rhinitis, pharyngitis, 
tonsillitis, or bronchitis), and 3) had 
a previous history of undergoing 
radiotherapy in the neck area.
In the control group, 15 subjects were 
given standard therapy consisting of 20 
mg of omeprazole every 12 hours and 1.8 
L of mineral water per day for 2 weeks. 
Meanwhile, in the treatment group, 15 
subjects were given 1.8 L of alkaline 
water per day and 20 mg of omeprazole 
every 12 h for two weeks. Both of groups 
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were evaluated after two weeks by 
reassessing clinical improvement using 
the RSI score.
Statistical analysis
aA normality test of the data was 
performed using the Shapiro-Wilk test, 
which showed a normal data distribution. 
Finally, the data were analyzed using the 
independent t-test or Wilcoxon test or 
Fischer’s exact test. A p value < 0.05 was 
considered significant. 
RESULTS
A total of 30 subjects who met 
the inclusion and exclusion criteria 
were randomized into two groups i.e. 
treatment and control groups.





•	Male [n (%)] 2 (13.3) 3 (20) 1.000*
•	Female [n (%)] 13 (86.7) 12 (80)
Age (mean ± SD years) 43.20 ± 9.76 45.60 ± 8.73 0.484**
Age categories [n (%)]
•	15 – 20 0 (0) 0 (0)
•	>20 – 30 2 (7) 1 (3)
•	>30 – 40 3 (10) 4 (13)
•	>40 – 50 7 (23) 6 (20)
 [n (%)]>50 – 60 3 (10) 4 (13)
Notes: *Independent t-test; **Fischer’s exact test.
    
TABLE 1 shows the characteristics 
of the subjects based on sex in the two 
groups, consisting of 5 (16.7%) male 
and 25 (83.3%) female subjects. The sex 
distribution in the two groups ware 
homogeneous (p = 1.0). The distribution 
of subjects based on age show that the 
highest number of subjects was in the 
41-50 years age group, which were 13 
(43%) subjects. The age distribution in 
the two groups ware homogeneous (p = 
0.484). The mean age in both groups was 
43 ± 9.756 years, with an age range of 21-
60 years.
TABLE 2. Distribution of chief complaints
Chief complaints n (%) 
Hoarseness 4 (13)
Throat clearing 11 (37)
Mucus in the throat 5 (17)
Swallowing difficulty 2 (7)
Coughing after eating or lying down 1 (3)
Breathing difficulty 0 (0)
Nagging cough 1 (3)
A lump in the throat 6 (0.2)
Heart-burn, chest pain, indigestion, gastric acid reflux 0 (0)
The most frequent main complaint 
that brought subjects for treatment 
was throat clearing [11 patients (37%)], 
followed by mucus in the throat [5 
patients (17%)]. Meanwhile, complaints 
of heartburn and difficulty in breathing 
were not the main complaints that 
brought subjects to come for treatment.
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Pre-test 22.27 ± 3.26 24.47 ± 2.83 0.058*
Post-test 18.27 ± 2.92 17.33 ± 2.09 0.322*
p <0.001¶* <0.001¶*
Notes: *Independent t-test (significant if the p value 
was <0.05)
TABLE 3 shows an insignificant 
decrease in the RSI score (p >0.005) after 
two weeks of intervention both in the 
treatment and control groups. The mean 
pre-test RSI scores in the control and 
treatment groups were 22.27 ± 3.26 and 
24.47 ± 2.83 respectively. Meanwhile, 
the mean post-test RSI scores in the 
treatment and control groups were 18.27 
± 2.92 and 17.33 ± 2.09, respectively. 
The results of statistical tests showed 
no significant differences (p >0.05) in 
the mean RSI score before and after the 
intervention both in the treatment and 
control groups.






Throat clearing 0.004 <0.001
Mucus in the throat 0.002 0.001
Swallowing difficulty 0.414 0.034
Coughing after eating or lying down 0.020 0.021
Breathing difficulty 0.157 0.109
Nagging cough 0.020 0.001
A lump in the throat 0.008 0.001
Heartburn, chest pain, indigestion, gastric acid reflux 0.248 0.013
Notes: αWilcoxon test; *Significant
Based on the statistical analysis 
(TABLE 4), we found a significant 
improvement in RSI score of the control 
group, in exception to swallowing 
difficulty, breathing difficulty, heartburn, 
chest pain, indigestion, and gastric 
acid reflux complaints. Meanwhile, 
in the treatment group, we found 
improvements in almost all complaints, 
except for breathing difficulty.
DISCUSSION
This study involved 30 LPR patients, 
with a mean age of 43 ± 9.756 y.o (range 
21 to 60 years). The highest number 
of subjects was found in the 51 to 60 
years age group (23%). This result was 
different from previous studies, where 
LPR was mostly found in the 41-50 age 
groups (43%). Other studies showed 
that LPR cases were mostly found in 
subjects aged over 60 years. The results 
of this study indicated that LPR cases 
were more frequently found in female 
subjects (83.3%) compared to male 
subjects (16.7%), with a ratio of 1.7:1.9,10
The most frequent main complaint 
that brought subjects for treatment 
was throat clearing [11 patients (37%)]. 
Meanwhile, complaints of heartburn 
and difficulty in breathing were not the 
main complaints that brought subjects to 
come for treatment.
RSI scoring measurement analysis
No significant difference in mean 
pre-test and post-test RSI scores between 
the treatment and the control groups 
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(p>0.05) was observed. This result 
might be caused by the gastric feedback 
mechanism to detect an increased 
pH, thus signalling the gastric wall to 
produce more chloric acid to return 
normal gastric acidity (pH of 4), and 
causing lesions on the laryngeal mucosa. 
All of these conditions eventually affect 
the RSI score measurement.11,12
Idit was found that the RSI scores 
increased in almost all complaints 
in the treatment group compared to 
the RSI scores in the control group 
(TABLE 4). These improvements 
include improvement in symptoms of 
hoarseness, throat clearing, mucus in the 
throat, swallowing difficulty, coughing 
after eating or lying down, nagging 
cough, a lump in the throat, heartburn, 
chest pain, indigestion, and gastric acid 
reflux. Meanwhile, in the control group, 
there were only a few improvements in 
several complaints, such as hoarseness, 
clearing throat, mucus in the throat, 
nagging cough, and a lump in the throat. 
These results might be caused of the 
omeprazole given to each subject in both 
groups. Omeprazole was believed to 
reduce the complaints, given its function 
as a proton-pump inhibitor (PPI) agent.13,14 
This statement was proved by subjects 
in the treatment group, who received 
omeprazole-alkaline water regimen, 
experienced more improvements 
compared to subjects in the control 
group. These symptoms may be caused by 
high hydrogen content in alkaline water 
acting as an anti-oxidant to reduce the 
reactive oxygen species (ROS) levels in 
the body. ROS is a very reactive molecule 
formed primarily in the electron 
transport chain in mitochondria. ROS 
plays an important role in the normal 
physiological process, such as regulation 
of protein phosphorylation redox, ion 
channel, and transcription process. 
Excessive production of ROS would 
cause cell and tissue damage leading to 
an urgent need for an anti-oxidant to 
neutralize the ROS. Alkaline water with 
pH of 8.8 may help reducing acid reflux 
because higher pH level will inhibit 
pepsin, an enzyme involved in dietary 
protein breakdown and the main cause 
of decreased acidity.6,7,15
CONCLUSION
There are clinical improvements 
both in the control and treatment groups. 
However, the clinical improvements 
are not significantly different between 
subjects given either alkaline water 
or mineral water. Future studies are 
needed with a consideration of the 
duration of therapy based on the LPR 
management guidelines to improve the 
clinical improvements.
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